BRD7 and osteosarcoma: In this report, we demonstrate that BRD7, as a new substrate of APC/C-E3 ligase during the cell cycle, is a tumor suppressor in osteosarcoma, and this APC/C-BRD7 pathway may provide a potential therapeutic target for treating osteosarcoma.